INS and metabolic dysfunction-associated steatotic liver disease: Many of the mechanisms that explain the relationship between low-sodium intake and the development of NAFLD in animals have already been observed in humans, such as the increased activity of the RAAS, insulin resistance, and disturbance in lipid metabolism [4].